VISID - Vaccine naive control
The population is composed of participants who are 12 years old and older, are vaccine naive and immunocompetent.
The population is composed of participants who are 12 years old and older, are vaccine naive and immunocompetent.
-
Minimum age
-
12
-
Newborns
-
-
Twins
-
-
Countries
-
-
Territory
-
-
Ethnic Origin
-
-
Health Status
-
-
Other Criteria
-
Inclusion: Able to provide informed consent, able to speak either English or French, available for ongoing follow-up as required.
Exclusion: Subclass deficiency or isolated IgA deficiency without confirmatory testing for poor polysaccharide vaccine response, recent (<6 months) or concomitant use of other immunosuppressive agents (only for subgroup AII), evidence of HIV infection, contraindicated from receiving COVID-19 vaccines.
-
Sources of recruitment
-
-
Specific Population
-
-
Supplementary Information
-
Healthy controls will be recruited from family and friends of the patient participants, hospital administrative staff who have not been vaccinated, patients at Public Health Immunization Clinics, and previous study participants listed in the Canadian Center for Vaccinology database. We will also engage patient organizations, Public Health Units, and local media through each hospital’s Public Relation’s team to assist in the study advertisement. A study webpage will be created as an additional recruitment strategy. Interested participants can register and provide contact information for the study coordinator to proceed with consenting process.
-
Number of Participants
-
33
-
Number of Participants with Biological Samples
-
33